Field trial permissions for gene edited agriculture

Introduction

Gene editing is a modern biotechnology technique used to modify specific genetic sequences in plants. Techniques such as CRISPR-Cas enable scientists to develop crops with improved productivity, disease resistance, nutritional quality and tolerance to environmental stress. Unlike conventional genetic modification, certain gene-editing techniques may not introduce foreign DNA into the final plant.

Field trials are conducted to evaluate the performance, stability and environmental effects of gene-edited crops under agricultural conditions. However, these trials require appropriate regulatory supervision to protect biodiversity, farmers, consumers and the environment.

In India, field trial permissions depend on the type of gene-editing technique used, the characteristics of the resulting plant and the applicable biosafety regulations.

Legal framework in India

1. Environment (Protection) Act, 1986

The Environment (Protection) Act, 1986, provides the primary statutory foundation for regulating genetically engineered organisms. Section 6 empowers the Central Government to make rules governing activities involving potentially hazardous substances and organisms.

Section 8 requires compliance with prescribed safeguards when handling hazardous substances. These provisions support regulatory supervision of biotechnology experiments that may create environmental risks.

2. Rules, 1989

The Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms/Genetically Engineered Organisms or Cells Rules, 1989, establish India's principal regulatory framework for genetically engineered organisms.

The framework provides for several regulatory bodies:

Institutional Biosafety Committee (IBSC): Supervises biotechnology research within an institution.

Review Committee on Genetic Manipulation (RCGM): Reviews research and development involving genetically engineered organisms.

Genetic Engineering Appraisal Committee (GEAC): Evaluates activities involving environmental release and other matters assigned under the Rules.

State Biotechnology Coordination Committee (SBCC): Coordinates and monitors relevant activities at the state level.

District Level Committee (DLC): Provides district-level monitoring and oversight.

The required permission depends on the nature of the experiment and the applicable regulatory classification.

3. DBT guidelines on genome-edited plants, 2022

The Department of Biotechnology issued guidelines for the safety assessment of genome-edited plants in 2022. These guidelines distinguish certain categories of genome editing from conventional transgenic modifications.

The guidelines address two important categories:

SDN-1: Genome editing involving small changes without introducing foreign genetic material.

SDN-2: Genome editing involving targeted changes using a repair template, without retaining foreign DNA in the final plant.

Certain SDN-1 and SDN-2 genome-edited plants are exempted from specified provisions of the 1989 Rules, subject to prescribed conditions and verification requirements.

4. Biological Diversity Act, 2002

The Biological Diversity Act regulates access to biological resources and associated traditional knowledge, subject to applicable exemptions. Research involving indigenous plant varieties or biological resources may raise questions concerning access permissions and benefit-sharing obligations.

Procedure for obtaining field trial permission

The approval process depends on whether the gene-edited crop falls within an exempted category or remains subject to the full regulatory framework.

For regulated crops, the applicant institution must provide relevant scientific and safety information to the competent authorities. This may include the genetic characteristics of the plant, its intended agricultural use, potential environmental effects and proposed monitoring arrangements.

Regulatory review may consider:

Genetic characteristics and stability of the edited plant.

Potential effects on non-target organisms.

Possibility of unintended environmental consequences.

Effects on biodiversity and related agricultural systems.

Food and feed safety, wherever applicable.

Proposed monitoring and risk-management arrangements.

Permission for laboratory research does not automatically authorise field trials. Similarly, permission for a confined field trial does not automatically authorise commercial cultivation.

Restrictions and regulatory safeguards

Field trials must comply with the conditions imposed by the competent regulatory authority. These may include restrictions on trial locations, monitoring requirements, record maintenance and reporting of unexpected events.

The 2022 DBT guidelines are particularly significant because they recognise that certain gene-edited plants without foreign DNA may present different regulatory considerations from transgenic organisms.

However, exemption is not automatic for every CRISPR-developed plant. The technique, final genetic characteristics and applicable verification requirements must be considered. Other applicable agricultural, environmental, food-safety and biodiversity laws may continue to operate.

Important judicial decisions

1. Aruna Rodrigues v. Union of India (2024)

The Supreme Court considered regulatory and environmental issues concerning genetically modified mustard. The opinions differed on important questions, and the matter was referred to a larger bench. The proceedings demonstrate the importance of scientific transparency, regulatory accountability and careful assessment before permitting genetically modified crops.

2. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999)

The Supreme Court highlighted the importance of scientific expertise in environmental decision-making. It recognised that technical environmental disputes require specialised knowledge. This principle is relevant when authorities assess the potential risks of gene-edited agricultural crops.

3. Vellore Citizens' Welfare Forum v. Union of India (1996)

The Supreme Court recognised the precautionary principle as part of Indian environmental law. This principle supports preventive regulatory action where scientific uncertainty exists concerning possible environmental harm.

4. Narmada Bachao Andolan v. Union of India (2000)

The Supreme Court discussed environmental assessment in the context of development projects. The judgment illustrates the importance of considering environmental consequences while evaluating activities involving public and ecological interests.

These decisions do not directly establish a separate permission procedure for gene-edited crops. They provide broader environmental principles applicable to biotechnology regulation.

Challenges and recommendations

The regulation of gene-edited agriculture faces challenges involving scientific uncertainty, classification of different editing techniques, public acceptance and coordination between regulatory authorities.

A transparent permission system should provide clear exemption criteria, scientifically sound risk assessments, public access to relevant regulatory information and effective post-trial monitoring. Farmers and affected communities should also receive reliable information about the characteristics and limitations of approved crops.

Conclusion

Field trial permissions for gene-edited agriculture are essential for ensuring that agricultural innovation develops responsibly. India's 1989 Biosafety Rules and the DBT Guidelines, 2022, provide the principal regulatory framework, including conditional exemptions for certain SDN-1 and SDN-2 plants. Judicial decisions concerning precaution, scientific expertise and environmental protection strengthen the principles governing regulatory assessment. A balanced approach must encourage scientific research while protecting biodiversity, agricultural interests and public health.